<DOC>
	<DOCNO>NCT02680106</DOCNO>
	<brief_summary>Evaluation safety performance SPINNER device wind dress treatment donor-site wound ( DSW )</brief_summary>
	<brief_title>Evaluation SPINNER Device Application Wound Dressing : Treatment Split Skin Graft Donor Sites</brief_title>
	<detailed_description>The SPINNER hand hold , portable electro-spinning device produce personalize in-situ nanofiber dressing treatment external burn wound . The dress non-adherence , high absorbance , bacterial protection , easy pain-free peel characteristic show excellent conformability optimal coverage wound . The objective study evaluate safety performance SPINNER device wind dress treatment donor-site wound ( DSW ) size 10-200 cm2 . The study include four site Israel : Sheba Medical Center , Tel Hashomer Meir Medical Center , Kfar Saba Kaplan Medical Center , Rehovot Souraski Medical Center , Tel Aviv Study primary endpoint : 1 . Dermal Safety 2 . Wound heal time complete re-epithelialization 1 , 3 , 5 , 7 , 14 21 day post operation Study secondary endpoint : 1 . Ease use 2 . Pain assessment 1 , 3 , 5 , 7 , 14 21 day post operation 3 . Infection assessment 3 day post operation 21 day 4 . Device related adverse event SPINNER device wind dress Extended exploratory follow : Assessment itch scar wound closure time 12 month follow optional examination 24 month .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>The patient â‰¥ 18 year old enrolment . Both gender . Patients donor site wound , size 10200 cm2 , locate thigh partial thickness skingraft The patient able willing comply study procedure give write informed consent prior enrollment study Any known suspect systemic infection Any known sensitivity components/products use study Use penicillamine , corticosteroid immunosuppressive medication within two month prior enrollment , current use nonsteroidal anti inflammatory agent discontinue , likely prescribed medication medication know adversely affect wound heal study participation Major uncontrolled systemic disorder hepatic , renal , neurologic , endocrinologic disorder . Patients undergo repeat skin graft harvest donor site Patients burn 15 % TBSA Requires immersion hydrotherapy time study participation Bleeding disorder Skin disorder psoriasis , pemphigus , Toxic Epidermal Necrolysis ( TEN ) , StevensJohnson Syndrome ( SJS ) , pyoderma gangrenosum exfoliative disorder Terminal patient Soldiers Prisoners Female patient pregnant nursing , childbearing potential use adequate contraception Participation another clinical trial within 30 day prior Screening Visit study . Psychiatric patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Nanofibers</keyword>
	<keyword>Dressing</keyword>
	<keyword>Donor site</keyword>
	<keyword>Polycaprolactone</keyword>
</DOC>